About this trial
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female reported in database and not an invalid entry
Age reported and not an invalid entry
Treatment date in 2011 or later.
Disqualifiers
None
Trial population
Individuals who received mental health treatment at a Greenbrook Center and the data is available in their database.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Patients treated with NeuroStar TMS
Devicenon-invasive brain stimulation device
Patients treated with Esketamine
Drugnasal spray for treating depression
Treatment groups
Trial outcomes
Primary outcomes
change in clinical outcome scores from baseline to post treatment
real-world efficacy of NeuroStar TMS as compared to Esketamine in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9
Sponsors and contacts
Click on the lead sponsor to view all of their trials.